Skip to main content
Premium Trial:

Request an Annual Quote

Whitehead’s Lander Joins Aclara BioSciences Board



OUNTAIN VIEW, Calif.--Aclara BioSciences announced that Eric Lander has joined its board of directors. Lander is director of the Whitehead/MIT Center for Genome Research, a member of the Whitehead Institute for Biomedical Research, and a founder and director of Millennium Pharmaceuticals.

"Aclara’s technology can dramatically accelerate numerous areas of genomics research," said Lander. He noted that the company "has put in place the business relationships to enable it to take advantage of these opportunities." Joseph Limber, Aclara’s president and CEO, said Lander’s "knowledge, experience, and insights will be extremely valuable as we develop our microfluidics technology for a broad range of genomics applications." Aclara uses a proprietary microfluidic lab-on-a-chip technology to create new tools for genomics and pharmaceutical drug screening.

Filed under

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.